✦ LIBER ✦

Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion

✍ Scribed by Haberman, Rebecca P; Samulski, R Jude; McCown, Thomas J

Book ID: 109933277
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 996 KB
Volume: 9
Category: Article
ISSN: 1078-8956
DOI: 10.1038/nm901

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adeno-Associated Virus Vector-Mediated E

Adeno-Associated Virus Vector-Mediated Expression and Constitutive Secretion of Galanin Suppresses Limbic Seizure Activity

✍ Thomas J. McCown 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 208 KB

Neuronal-specific and nerve growth facto

Neuronal-specific and nerve growth factor-inducible expression directed by the preprotachykinin-A promoter delivered by an adeno-associated virus vector

✍ P.T. Harrison; R.G. Dalziel; N.A. Ditchfield; J.P. Quinn 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 241 KB

Adeno-associated virus-mediated expressi

Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo

✍ Haberman, R P; Samulski, R J; McCown, T J; Foti, S 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 105 KB

Efficient coexpression and secretion of

Efficient coexpression and secretion of anti-atherogenic human apolipoprotein AI and lecithin-cholesterol acyltransferase by cultured muscle cells using adeno-associated virus plasmid vectors

✍ Fan, L; Drew, J; Dunckley, M G; Owen, J S; Dickson, G 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 100 KB

Suppression of ovarian cancer by muscle-

Suppression of ovarian cancer by muscle-mediated expression of soluble VEGFR-1/Flt-1 using adeno-associated virus serotype 1-derived vector

✍ Yuji Takei; Hiroaki Mizukami; Yasushi Saga; Ichiro Yoshimura; Yoko Hasumi; Takes 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 659 KB

## Abstract Vascular endothelial growth factor (VEGF) is known to play a major role in angiogenesis in a variety of tumors. A soluble form of Flt‐1 (sFlt‐1), a VEGF receptor, is potentially useful as an antagonist of VEGF, and accumulating evidences suggest the applicability of sFlt‐1 in tumor supp